AI주식인사이트AI Stock Insight
B

우진비앤지

018620KOSDAQ의약품 제조업

59.8 / 100

Reference Date: 2026-06-10

Financial Score12.0 / 40
News Sentiment20.8 / 25
Momentum15.0 / 20
Disclosure12.0 / 15
AI Analysis: PBR is significantly undervalued vs. peers but ROE is below the industry average. Surged 314.9% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Ujin B&G is a specialized company in animal pharmaceuticals, producing medications, vaccines, and supplements, with 35% of its sales coming from exports. Its subsidiaries, OSPI and Bawow Korea, manufacture pet food and treats, and the company aims to expand its market share through eco-friendly products and vaccine development.

Number of Employees

103people

Average Salary

54.2M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 11.934.0Point
PBR
0.28Industry Average 0.897.0Point

Half of industry avg (excellent)

ROE
-5.38Industry Average 4.010.0Point

Well below industry avg

Debt Ratio
24.70Industry Average 12.430.5Point

2.0x industry avg (risky)

Trend 2023~20250.5 / 10 points
Revenue Growth Rate
0.5 / 3

Avg ▼2.8% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼25.3% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -4.2% (declining, 3yr)

Detailed News Sentiment

5 totalPositive 5Neutral 0Negative 0Average Sentiment Score 83

Detailed Momentum

52-week position8.0Point

Near 52w high (88%, uptrend)

Current 3,095Won52-week high 3,40052-week low 670
1-month return6.0Point

1m +314.88% (strong rise)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

12 totalPositive 1Neutral 11Negative 0
  • Neutral주식등의대량보유상황보고서(일반)2026-06-09
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-06-09
  • Neutral임원ㆍ주요주주특정증권등거래계획보고서2026-06-09
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-06-09
  • Neutral임원ㆍ주요주주특정증권등거래계획보고서2026-06-09